Bioequivalence study of Glimepride Tablet [Study As­sess­ment]

posted by Ibrahim Komeil – Egypt, 2021-02-15 11:07 (722 d 05:43 ago) – Posting: # 22208
Views: 1,226

Dear All
I hope you are all fine
Recently i had got results of bioequivalence study for Glimepride Tablet 1 mg applying two way crossover design with 26 volunteers
The results are shown below:
Cmax: PI = 0.75, 90% CI [0.672 - 0.845]
AUCt:  PI = 0.82, 90% CI [0.754 - 1.042]

I am confusing to be sure that the test product is bad , so i am asking your help to know the real cause of these results.

Thank you in advance

Edit: Category changed; see also this post #1[Helmut]

Complete thread:

UA Flag
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
23 visitors (0 registered, 23 guests [including 8 identified bots]).
Forum time: 16:50 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz